- Home
- PLUG vs CNTA Comparison
PLUG vs CNTA Comparison
Compare PLUG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- CNTA
- Stock Information
- Founded
- PLUG 1997
- CNTA 2020
- Country
- PLUG United States
- CNTA United Kingdom
- Employees
- PLUG N/A
- CNTA N/A
- Industry
- PLUG Industrial Machinery/Components
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- CNTA Health Care
- Exchange
- PLUG Nasdaq
- CNTA Nasdaq
- Market Cap
- PLUG 1.6B
- CNTA 1.6B
- IPO Year
- PLUG 1999
- CNTA 2021
- Fundamental
- Price
- PLUG $1.16
- CNTA $13.07
- Analyst Decision
- PLUG Hold
- CNTA Strong Buy
- Analyst Count
- PLUG 16
- CNTA 10
- Target Price
- PLUG $1.76
- CNTA $28.78
- AVG Volume (30 Days)
- PLUG 103.7M
- CNTA 1.2M
- Earning Date
- PLUG 08-07-2025
- CNTA 08-12-2025
- Dividend Yield
- PLUG N/A
- CNTA N/A
- EPS Growth
- PLUG N/A
- CNTA N/A
- EPS
- PLUG N/A
- CNTA N/A
- Revenue
- PLUG $642,224,000.00
- CNTA $15,000,000.00
- Revenue This Year
- PLUG $17.73
- CNTA N/A
- Revenue Next Year
- PLUG $26.15
- CNTA N/A
- P/E Ratio
- PLUG N/A
- CNTA N/A
- Revenue Growth
- PLUG N/A
- CNTA 118.88
- 52 Week Low
- PLUG $0.69
- CNTA $8.46
- 52 Week High
- PLUG $3.34
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- PLUG 54.26
- CNTA 52.42
- Support Level
- PLUG $1.09
- CNTA $12.74
- Resistance Level
- PLUG $1.27
- CNTA $14.27
- Average True Range (ATR)
- PLUG 0.16
- CNTA 0.68
- MACD
- PLUG -0.01
- CNTA 0.11
- Stochastic Oscillator
- PLUG 31.48
- CNTA 55.99
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.